Cincor Pharma Inc (CINC) PT Raised to $50 at Jefferies
Tweet
Share
E-mailGet Alerts CINC Hot Sheet
Price: $28.89 -0.14%
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 32 | New: 11
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 32 | New: 11
Join SI Premium – FREE
Jefferies analyst Dennis Ding raised the price target on Cincor Pharma Inc (NASDAQ: CINC) to $50.00 (from $30.00) while maintaining a Buy rating.
You May Also Be Interested In
- JPMorgan Downgrades Grab Holdings Inc. (GRAB) to Underweight, 'Recommend tactical UW on risk of earnings missing expectations'
- Miromatrix Medical inc. (MIRO) PT Lowered to $18 at Craig-Hallum
- Canaccord Genuity Downgrades Calyxt Inc. (CLXT) to Hold
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
